Suchergebnisse - "Klion, Amy D"

PubPharm (240)

51

Contributions of Eosinophils to Human Health and Disease

enthalten in: Annual review of pathology | 2020

von Klion, A. | Ackerman, S. | Bochner, B.

52

Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection : an observational cohort study

enthalten in: The Lancet. Infectious diseases | 2020

von Pion, S. | Nana-Djeunga, H. | Niamsi-Emalio, Y. | +9

CommentIn: Lancet Infect Dis. 2020 Jan;20(1):8-10. - PMID 31676243

53

Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2019

von Stokes, K. | Yoon, P. | Makiya, M. | +6

54

Advances in eosinophilic diseases in 2018

enthalten in: The Journal of allergy and clinical immunology | 2019

von Klion, A. | Rothenberg, M.

55

Loa loa Microfilariae in Skin Snips : Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Nana-Djeunga, H. | Fossuo-Thotchum, F. | Pion, S. | +7

56

Siglec-7 on peripheral blood eosinophils : Surface expression and function

enthalten in: Allergy | 2019

von Legrand, F. | Landolina, N. | Zaffran, I. | +4

57

Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders : Receptor expression and targeting using chimeric antibodies

enthalten in: The Journal of allergy and clinical immunology | 2019

von Legrand, F. | Cao, Y. | Wechsler, J. | +14

58

Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome

enthalten in: The New England journal of medicine | 2019

von Kuang, F. | Legrand, F. | Makiya, M. | +22

59

Charcot-Leyden crystals : solving an enigma

enthalten in: Blood | 2018

von Klion, A.

CommentOn: Blood. 2018 Nov 15;132(20):2183-2187. - PMID 30154112

60

Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome

enthalten in: The journal of allergy and clinical immunology. In practice | 2018

von Kuang, F. | Fay, M. | Ware, J. | +7